Omni 128 cm PET/CT imaging system: comparing new scanner with standard PET/CT

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults already scheduled for a clinically indicated PET/CT will receive an additional research scan on the Omni 128 cm PET/CT. Researchers will compare image quality and data between the standard clinical scan and the Omni system to assess performance. The study involves a single visit with no follow-up and may support regulatory submissions and future imaging technology improvements. Participation is limited to those who meet the eligibility criteria and can provide informed consent.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must have a clinical indicated PET/CT exam scheduled including (but not limited to) one of the following radiopharmaceutical tracers: Fluorodeoxyglucose (FDG or 18F-FDG), 18F-DCFPyL; 68Ga- PSMA; 68Ga Dotatate; 18F Amyloid (18F- Florbetapir, 18F-Florbetaben, or 18F-Flutemetamol), or Other standard PET tracers;
* Age ≥ 18 years old at time of consent;
* Able to provide informed consent; AND,
* Has the necessary mental capacity to understand instructions and is able to comply with protocol requirements.

Exclusion Criteria:

* Who, per the site's SOPs, has any condition that would prevent the clinically indicated PET/CT from proceeding (i.e., pregnancy, breastfeeding, renal impairment, elevated blood glucose, etc.);
* Who were previously enrolled in this study;
* Who need urgent or emergent care;
* Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results, constitute a health hazard for the subject;
* Unwilling to have GEHC personnel present during scans; OR,
* Unable to tolerate the exam.

Where it's running

• Stanford University
  Stanford, California, United States Recruiting

Study contacts

• Study coordinator: Erin Terrell, MS
• Email: erin.terrell@gehealthcare.com
• Phone: 262-449-3363

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DLL3-targeted PET/CT for small cell lung cancer

  This study tests whether DLL3-targeted PET/CT can better detect lesions in people with suspected or confirmed small cell lung cancer compared with standard imaging.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07677787

• FAP-targeted PET and near-infrared fluorescence imaging for resectable non-small cell lung cancer

  We are testing whether FAP-targeted PET and near-infrared fluorescence can help find residual tumor and guide surgery in people with stage II–IIIB resectable non-small cell lung cancer after neoadjuvant therapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07498933

• PET scan targeting CDH3 for lung tumors

  This will test whether a new PET imaging agent called 68Ga-TOI-1 that targets CDH3 can better detect and stage lung tumors and help tell malignant from benign pulmonary nodules in adults with suspected or confirmed non-small cell lung cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07487883

• 68Ga-XACP3 PET/CT for detecting prostate cancer lesions

  This study will test whether 68Ga-XACP3 PET/CT can find tumor lesions in adults with prostate cancer or suspected recurrence compared with the standard 68Ga-PSMA PET/CT.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07242014

• Using 68Ga-MY6349 PET/CT to track response to Trop2 antibody‑drug therapy in NSCLC

  This will see if serial 68Ga-MY6349 PET/CT scans can predict how people with metastatic NSCLC respond to Trop2-targeted antibody‑drug treatment.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07151898

• 68Ga-MY6349 PET/CT to detect Trop-2 in solid tumors

  This scan will see if a new 68Ga-MY6349 PET/CT can detect Trop‑2 on tumors in adults with solid tumors.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07046702

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.